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ABSTRACT

Influenza transcribes viral mRNA in the host cell nucleus and the viral
mRNAs must be exported for translation in the cytoplasm. Most cellular mRNA

nuclear export is mediated by Nxf1 while select mRNAs utilize Crm1. Published

results in kidney cells reveal no dependence on Crm1 but show select influenza

mRNA nuclear export is dependent on Nxf1. Influenza infects cells of the

respiratory tract; thus A549 human lung cells are likely a better model for
influenza infection than HEK 293T or MDCK cells. I utilized expression of
Dominant Negative Nxf1 protein (DN-Nxf1) to inhibit Nxf1 nuclear export (Kang,
1999) in both kidney cells (HEK 293T) and lung cells (A549). In agreement with
published data using siRNA to down-regulate Nxf1, expression of DN-Nxf1

resulted in inhibition of HA, NS1, M1, and M2, but not NP and PB2 mRNA
nuclear export in 293T cells. Quantitative PCR showed that DN-Nxf1 expression

resulted in 43%, 74%, 18%, and 8% reductions in cytoplasmic HA, NA, M, and
NS mRNAs. Interestingly, expression of DN-Nxf1 in A549 cells inhibited both NP

and HA mRNA nuclear export, revealing a cell type difference for influenza NP

mRNA nuclear export. Quantitative PCR showed that DN-Nxf1 expression
resulted in 13%, 30%, 74%, 30%, and 16% reductions in cytoplasmic HA, NP,

NA, M, and NS mRNAs. Similar to results obtained with 293T cells, polymeraseencoding mRNAs showed only minimal dependence on Nxf1. Quantitative PCR

confirmed no significant difference in cytoplasmic PB2 mRNA in both A549 and
293T cells. To strengthen the evidence that Nxf1 is utilized for NP and HA mRNA

nuclear export, but not polymerase encoding mRNAs, Nxf1 was immunopurified

along with associated mRNAs in A549 cells. NP, NA, HA, NS1, NS2, M1, and M2
mRNAs were found specifically associated with Nxf1 but PB1, PB2, and PA
mRNAs were not These results support the hypothesis that some influenza
mRNAs utilize atypical mRNA nuclear export; defining this pathway may lead to

discovery of novel antiviral targets. Furthermore, our data reveal a cell type
difference in the role of host Nxf1 for influenza NP mRNA nuclear export.
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CHAPTER ONE
BACKGROUND AND SIGNIFICANCE

Societal Effects of Influenza
Every year influenza epidemics are responsible for three to five million

hospitalizations and 250,000 to 500,000 deaths throughout the world (CDC).
Epidemics are characterized by sustained, widespread person-person

transmission within a circumscribed area (Bouvier & Palese, 2008).

Epidemics peak in the winter season, and are estimated to be responsible for
$10 billion in medical costs and a total economical burden of $87 billion each

year (Molinari et al., 2007). Three times during the 20th century the world
experienced influenza pandemics: the 1918 Spanish flu, the 1957 Asian flu,

and the 1968 Hong Kong flu. Pandemics are characteristically similar to

epidemics, except the transmission is worldwide instead of within a
circumscribed area (Cox & Subbaro, 2000). The first pandemic experienced

in the 21st century was the 2009 novel H1N1 also known as the Swine flu
(WHO). The Swine flu was an estimated burden of $3 trillion on the global
economy (Lagace-Wiens et al., 2010).

Symptoms of an influenza infection involve quickly developing high
fever, dry cough, headache, muscle pain, general fatigue, sore throat, and a

runny nose (WHO). Influenza spreads when an infected person coughs and
droplets containing the virus are expelled into the air or onto the infected
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person’s hand, potentially breathed in by others or spread by contact (WHO).
The virus has an incubation period of roughly two days, and usually victims
recover from symptoms within a week without medical attention. However,
those at high risk, such as children under the age of two, elderly older than 65

years, and those with medical conditions involving the heart, lungs, liver,

blood, kidneys, or immunologically compromised, can go on to develop
severe illness possibly resulting in death (WHO).

Virion
The Influenza virus is a member of the Orthomyxoviridae family; a

family of enveloped, segmented, negative sense, single stranded RNA

(ssRNA) viruses (Resa-lnfante et al., 2010). There are three types of

Influenza, Influenza A, B, and C (Bouvier & Palese, 2008). All three types
share a common ancestry, but diverged genetically, preventing intra-type re

assortment (Bouvier & Palese, 2008). Influenza A viruses are responsible for
all known human pandemics and are the focus of this research. Influenza A is

further classified by the subtype of the virus, which is based upon the surface
glycoproteins of the virion; Hemagglutinin (HA) and Neuraminidase (NA)

(Bouvier & Palese, 2008). There are 16 and 9 subtypes of the HA and NA
glycoproteins, respectively (Bouvier & Palese, 2008). Only three HA

subtypes (H1, H2, and H3) and two NA subtypes (N1 and N2) have been

associated with human epidemics (Bouvier & Palese, 2008). This research
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utilizes the Udorn Influenza A H3N2 lab strain virus to investigate influenza

mRNA nuclear export.
Infectious Influenza A virions consist of three major structures, the
core, the matrix, and the envelope. The core of the virion consists of

structures referred to as the viral ribo nucleoprotein (vRNP) (Martin-Benito et

al., 2001). Each vRNP consists of one negative sense ssRNA segment
encapsulated by Nucleoprotein (NP), and bound at both the 3’ and 5’ ends by
the viral RNA-dependent RNA polymerase (RdRP). The RdRP is made up of

two basic proteins (PB1 and PB2) as well as an acidic protein (PA), which
together form the active RdRP, a heterotrimer (Resa-lnfante et al., 2010,

Bouvier & Palese, 2008). The positively charged pocket of NP allows for
interaction with the negatively charged phosphate backbone of the RNA

(Bouvier & Palese, 2008). Of the 7 proteins found in the virion, NP is found in
the most abundance, as its role is to nonspecifically bind the vRNA genome.
It is important to note that NP does not protect the RNA from RNases (Martin-

Benito et al., 2001, Bouvier & Palese, 2008). The vRNP in the core is
responsible for viral transcription and replication.
Surrounding the vRNPs is a matrix of M1 proteins, which is further

surrounded by a host-derived lipid bilayer envelope containing three
transmembrane proteins: HA and NA, which are external, and an ion channel
(M2), which is internal (Nayak et al., 2009, Bouvier & Palese, 2008). Because

the envelope is host derived, it contains cholesterol-enriched lipid rafts as well
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as non-raft lipids (Nayak et al., 2009). The HA and NA proteins are raft

anchored on the surface and play intricate roles in the infection and budding
process respectively. The M2 protein is loosely associated with lipid rafts

through a cholesterol binding protein, and plays a large role in the fusion of
the virion with the endosome (Nayak et al., 2009). The envelope surrounds

the virion and the shape can vary (Figure 1).
The influenza RNA genome is segmented and consists of eight

individual segments, which code for at least 11 different proteins (Bouvier &
Palese, 2008). Similar to cellular transcription, influenza transcription also

occurs in the nucleus so that host-splicing machinery can be utilized.

Influenza genes can be separated into three distinct categories; intronless
(segments 1-6; PB2, PB1, PA, HA, NP, and NA), intron containing (segments

7 and 8; M1 and NS1), and fully spliced (segments 7 and 8; M2 and NS2)
(Read & Digard, 2010, Bouvier & Palese, 2008). The genes can also be

categorized into Early (PB2, PB1, PA, NP and NS1), and Late (HA, NA, M1,

M2, and NS2), based simply upon the timing of protein expression (Hatada et
al, 1989).

Infection

Attachment and Entry
The target cells of choice for Influenza A virus are respiratory epithelial
cells. Influenza A viruses recognize their target cells by N-acetylneuraminic
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(sialic) acid residues on the cell surface (Bouvier & Palese, 2008). Once

there is viral attachment to the sialic acid residue on the cell surface, the

virion is internalized via receptor-mediated endocytosis (Cros et al., 2005).

Due to the low pH environment of the endosome, the acidity causes a
conformational change in the HA protein (Cros et al., 2005, Bouvier & Palese,

2008). The conformational change in HA exposes a fusion peptide, which

facilitates the fusion of the viral and endosomal membranes, creating a pore
through which vRNPs can escape into the cytoplasm (Cros et al., 2005,
Bouvier & Palese, 2008). Hydrogen ions are pumped into the virion via the
M2 ion channel and leads to acidification of the inside of the virion, which

causes disruption of protein-protein interactions; mainly dissociation of the
vRNP from the M1 protein matrix (Cros et al., 2005, Bouvier & Palese, 2008).

This is a critical step for proper release of the vRNPs to the cytoplasm. The
Nuclear Localization Signals (NLSs) found on vRNP proteins allows vRNP

nuclear localization, the site of Influenza A replication and transcription (Cros

et al., 2005, Resa- Infante, Martin-Benito et al., 2001) (Figure 2).

Replication and Transcription
Once the vRNP reaches the nucleus, viral transcription (formation of
mRNAs which are destined to be translated into proteins) begins. Both

cellular and viral mRNAs consists of the genetic information flanked by a cap
structure at the 5' end and a poly A tail at the 3’ end. Cellular mRNAs obtain
a 5’ cap via Capping Enzyme complex, which is found associated with RNA
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Polymerase 11. The poly-Atail is added via Poly-A polymerase, which adds

adenine residues to terminated mRNA transcripts in a template independent

manner, resulting in poly-adenylated mRNAs. In contrast, Influenza mRNAs
obtain their 5’ cap by stealing the caps off host pre-mRNAs. PB2, an 82 kDa

protein, and PA, a 78 kDa protein, are both involved in the cap-snatching
process due to their cap binding and endonucleolytic properties, respectively.

These stolen caps act as primers for the transcription of the viral mRNA by
PB1, an 83 kDa protein, which possesses the polymerase activity. Influenza
mRNAs obtain their poly-A tail via a stuttering mechanism, by the viral RdRP,

triggered by a short stretch of Uracils, usually 5-7, at the 5’ end of the vRNA

template, resulting in polymerization of multiple adenine residues or a poly-A
tail (Bouvier & Palese, 2008). Once capped and poly-adenylated, the viral
mRNAs visually look the same as host mRNAs (Figure 3).

After viral protein synthesis and accumulation of viral NP and RdRP

proteins, replication (formation of progeny vRNA) will begin. Replication is
unprimed and involves the formation of a full-length positive sense copy RNA

molecule, cRNA, which is encapsulated by free NP and bound at the ends by

viral polymerase proteins. In the second step in the replication process, the
cRNA is used as template by the RdRP to polymerize the end replication

product, vRNAs, which are also encapsulated by free NP and bound by the

viral RdRP to form vRNPs. The new vRNPs can be used for assembly into
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new virions, repeated rounds of replication, or transcription to amplify viral
gene expression (Figure 3).

Splicing and Translation

Splicing plays an important role in influenza infection. As mentioned
above, each virion contains 8 segments, but its genome encodes for at least

11 different proteins. Segments 7 and 8 encode two proteins each, M1 and

NS1 which are intron containing viral mRNAs, and M2 and NS2 which are
fully spliced viral mRNAs. UAP56, a cellular splicing factor, and member of

the DEAD Box family of RNA helicases, was found to interact with influenza
NP (Naito et al., 2007, Nagata et al., 2008). This seems to suggest that the

splicing of influenza mRNAs may occur via canonical host splicing machinery.
However, when UAP56 is downregulated via siRNA, there is either slight or

no decrease in total viral load and no change in ratio of spliced mRNAs to
their respective intron containing mRNAs (Unpublished Newcomb Lab,

Nagata et al., 2008, Read & Digard, 2010). Therefore, while it is likely that
host-splicing factors such as RNA helicases are involved are involved in viral

mRNA splicing, it is not proven that viral mRNA splicing is occurring through a
typical host mechanism.
Cellular mRNA splicing is connected to mRNA nuclear export via
interactions between splicing factors and the nuclear export machinery,

specifically Nxf1 or Nuclear Export Factor 1. The bulk of cellular mRNAs exit

the nucleus via Nxf1 (Carmody & Wente, 2009). It appears that only select
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influenza viral mRNAs exit the nucleus though Nxf1 although published data
on influenza mRNA export remains sparse and conflicting. The focus of my

thesis research was to clarify the role of host Nxf1 in influenza viral mRNA
nuclear export and therefore nuclear trafficking will be discussed in detail in

Chapter 2. After nuclear export, the viral mRNAs are translated by host

ribosomes. Viral mRNAs encoding envelope proteins, HA, NA, and M2, are

translated by membrane bound ribosomes.
Assembly and Exit

In order for a virion to be infectious, it must contain all 8 vRNP

segments, thus once the 8 vRNP segments are replicated to abundant levels,
assembly and budding can commence (Nayak et al., 2009). Assembly and
budding occurs at the cell membrane, and is triggered by an accumulation of
vRNP bound M1 protein on the cytoplasmic side of the lipid bilayer (Bouvier &

Palese, 2008). HA will continually bind the virions to the sialic acid residues

until budding is complete, at which time the sialidase activity of NA will cleave
the sialic acid residues, releasing the progeny virions (Bouvier & Palese,

2008). Additionally, NA will remove sialic acid residues from the virions,

preventing binding of new progeny to each other and therefore leading to

enhanced infectivity (Bouvier & Palese, 2008). It is interesting to note that NA
is also believed to have the ability to break down respiratory tract secretions,
facilitating easier access to respiratory cells (Bouvier & Palese, 2008).
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Antigenic Variation

Influenza is difficult to control due to rapid genetic mutation resulting in

genetic variation. There are two methods by which influenza introduces
antigenic variation to the viral population, antigenic drift and antigenic shift.

Antigenic drift is caused by mutations during genome replication because the
RdRP has no proofreading abilities, resulting in genetic variation. This
produces viruses with mutations in the amino acid coding sequence of all

segments; however, HA/NA variable regions can best tolerate the changes
and even benefit from them by enabling the virus to evade the immune
system. Because neutralizing antibodies against influenza are HA/NA

specific, these antigenic changes may render a body’s previously established
antibody defenses against influenza subtypes useless. The second method
by which influenza introduces antigenic variation to its population is by means

of antigenic shift. Antigenic shift is characterized by a major change, which
results in an entirely new HA subtype introduced into the human population.

This can be paired with or without a change in the NA variant. There are two
ways by which antigenic shift can occur. The first involves transmission of an
influenza virus directly from an animal reservoir to humans without re

assortment, resulting in a new HA variant introduced to humans. The second
involves re-assortment of human and animal (i.e. swine, avian) viruses
resulting in a new HA subtype introduced, once again with or without a new

NA subtype (Cox & Subbaro, 2000). A new HA subtype will have no antibody
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defense throughout the population, thus antigenic shift results in more
effective changes than antigenic drift.

HA interacts with the host cell through sialic acid residues on the cell
surface. There are two types of sialic acid residues on cells as the terminal 2carbon of the sialic acid residue can bind either the 3-carbon or 6-carbon of

galactose, forming either a2-3 or a2-6 linkages, resulting in different steric

configurations of the terminal sialic acid (Bouvier & Palese, 2008). Different
HA subtypes exhibit preference for binding either a2-3 or a2-6 configurations
(Bouvier & Palese, 2008, Matrosovich, 2004). In human tracheal epithelial

cells, the a2-6 configurations tend to dominate, however, once the lower

respiratory tract is reached, a2-3 configurations can be found more frequently
than in the upper respiratory tract. With avian respiratory tract cells, a2-3

tends to dominate (Matrosovich, 2004). Avian influenza viruses prefer
infecting cells with a2,3 linkages, and because these linkages are found in

minimal amounts in the mammalian upper respiratory tract, infection of
humans with highly virulent H5N1, known as the bird flu, is very rarely

reported (Cox & Subbaro, 2000, Matrosovich, 2004).

However, in instances

of high exposure to H5N1, such as working on a farm with infected birds or
swimming in a virus laden pond/lake, humans have been know to be infected
(Adams & Sandrock, 2010). This is because a2,3 linkages can be found in

increased numbers in the lower respiratory region of humans (Ito et al., 2000).
The number of recorded human H5N1 infections as of 2009 was 433 and of
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these 433 infections, 262 cases resulted in death (Adams & Sandrock, 2010).

Previously it was believed that H5N1 would have to acquire one or more

mammalian influenza genes, however, newer publications have shown that

only 4 mutations are necessary (Cox & Subbaro, 2000, Imai et al., 2012).
In contrast to humans, the tracheal epithelium of pigs contains both
a2,3 and a2,6 linkages, rendering them susceptible to viruses of mammalian
as well as avian origin (Cox & Subbaro, 2000). This fact places pigs in a very

unique position because if a pig were to be infected simultaneously with

viruses of human as well as avian origin, it would act as a mixing vessel for

influenza re-assortment (Cox & Subbaro, 2000). The result of which would be

unique influenza viruses. This is thought to be the mechanism by which the
2009 triple re-assortment novel H1N1 virus emerged (CDC Swine).

Current Methods to Control Influenza Infection
Currently there are two preferred methods of controlling influenza
infection. The first method is by means of vaccination. This prevents

infection by production of antibodies against the specific NA/HA subtypes that

are predicted to be in circulation during that year’s epidemic, providing

immunity. Immunization is currently achieved through inactive virus vaccines
or live attenuated virus vaccines. Inactivated virus vaccines involves the

subcutaneous injection of a killed/inactivated virus, and live attenuated virus

vaccines are live viruses that encode viral proteins altered to diminish their
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pathogenic properties yet still elicit the desired immune response. Influenza
vaccines are solely based upon current HA/NA subtypes in circulation and
therefore predicted to be found in the next year’s epidemic. Because these

vaccines are based upon predictions, if the HA/NA subtype used in the
vaccine does not match that of the virus in circulation, the vaccine is rendered
useless. Additionally, due to the rapid evolution of the virus new vaccines are

required each succeeding year. Also of importance, is that current time
required for seasonal influenza vaccine production is roughly six months
(CDC). Thus, in times of pandemic, this time frame renders vaccines
ineffective. The most time consuming step of creating a vaccine is the

generation of a reference virus (Fauci, 2005). With the advent of reverse
genetics, efforts by the NIH to shorten vaccine production time have cut the

reference virus generation time down to a few weeks. An H5N1 vaccine
made utilizing this method is now in phase I clinical trials (Fauci, 2005).
Antiviral medications combat influenza by preventing viral spread.
There are two varieties of antiviral drugs aimed at influenza which target

either the activity of the M2 ion channel or the NA protein. Adamantanes,

specifically amantadine and rimantadine, are antiviral drugs that target the M2
ion channel (Pubbaraju et al., 2010). These two drugs inhibit viral replication
by blocking the ion-channel activity of the M2 protein, preventing the
dissociation of the vRNP from the M1 matrix (Pubbaraju et al., 2010, Cros et

al., 2005, Bouvier & Palese, 2008). Some subtypes such as H3N2 and the
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H1N1 subtype causing the 2009 pandemic have been reported to be
completely resistant to adamantane antivirals (Pubbaraju et al., 2010).

Neuraminidase inhibitors, specifically, oseltamivir and zanamivir, block the
function of the NA protein, thereby inhibiting the release of progeny virions

(Bouvier & Palese, 2008). Recent studies and clinical records have indicated

a rise in H1N1’s resistance to oseltamivir.
Nearly all strains of seasonal H1N1 found to be in circulation during

2008-2009 were resistant to oseltamivir treatment but only 1% of H1N1 from
the 2009 pandemic was found to be resistant to the treatment (Thorlund et al.,
2011, Okomo-Adhiambo, 2010). With 2009 H1N1 pandemic strains, it had
been believed there is no known resistance to zanamivir (Thorlund et al.,

2011, Okomo-Adhiambo, 2010). However, there was a recent discovery of a
2009 H1N1 pandemic strain with neuraminidase I223R mutation that showed

cross-resistance to all three available neuraminidase inhibitors, oseltamivir,
zanamivir and peramivir (Van der Vries et al., 2011). An infection with this

strain would leave a physician with no possible antiviral options to combat

influenza spread, since H1N1 was also shown resistant to adamantanes.
With the long wait times involved in the development and production of

vaccines as well as the continued development of antiviral resistance; there is

a need for new antiviral targets. Because influenza transcribes and replicates
in the host nucleus, mRNA nuclear export could potentially provide an

additional target to halt influenza spread. My study aims to define the nuclear
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mRNA export pathways of influenza viral mRNA. If viral mRNAs are
discovered to utilize neither known mRNA nuclear export pathway this would

indicate the mRNA exports via undefined mRNA nuclear export pathway. This
might be an atypical pathway not utilized by many host mRNAs and thus

might reveal novel antiviral target.
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Figure 1. Influenza A Virion.

Consists of 8 vRNP segments [(-) ssRNA bound at both ends by the RdRP,
and encapsulated by NP], surrounded by a matrix of M1 proteins, and a host
derived lipid bilayer envelope which contains three transmembrane proteins
[M2, HA, and NA].
Credit: Adams, S, and Sandrock, C. (2010). Avian Influenza: Update.
Medical Principles and Practice 19(6), 421-32.
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Figure 2. Influenza A Life Cycle.

Virion is internalized via receptor mediated endocytosis. vRNPs are released
to the cytoplasm, where NLSs found on vRNP proteins localize the vRNPs to
the nucleus, the site of influenza transcription and replication.
Credit: Palese, P, Shaw, ML. Orthomyxoviridae: The Viruses and Their
Replication 2001 Fields Virology, 5th edition D.M. Knipe and P.M. Howley,
Editors. 2006, Lippencott Williams and Wilkins: Philadelphia ISBN-10:0-78176060-7
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Figure 3. Influenza A Transcription And Replication.

Transcription results in a (+) sense mRNA that has 5’ cap and host
sequences and terminates early and stuttering to generate poly A tale.
Replication results in a (-) sense vRNA via a full length unmodified (+) sense
cRNA intermediate.
Credit: Racaniello, V. Influenza Viral RNA Synthesis. Virology Blog — About
Viruses and Viral Disease. Web. 29 Nov. 2011.
<http.7/www.virology.ws/2009/05/08/influenza-viral-rna-synthesis/>.
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CHAPTER TWO
NUCLEAR TRAFFICKING

Cellular Nuclear Trafficking
Nuclear Pore Complex

The major structure involved in nuclear trafficking is an assembly of
nucleoporins located within the nuclear envelope. This assembly of

nucleoporins is termed the Nuclear Pore Complex (NPC) (Durairaj et al.,

2009). Forming the bulk of the NPC is a central spoke complex, with
rotational symmetry surrounding the central transporter channel. In addition,

a ring forms the channel’s borders with the cytoplasm and nucleus (Durairaj
et al., 2009). Extending from each ring are eight fibrils, which are free at the
cytoplasmic side, but come together to form a basket structure at the nuclear
side (Durairaj et al., 2009) (Figure 4).

Molecules with a molecular weight less than 40,000 to 50,000 are

understood to freely diffuse through the NPC. However, larger molecules
require a nuclear localization signal (NLS) or a nuclear export signal (NES).

These epitopes allow proteins to be actively transported into or out of the
nucleus, through interaction with components of the NPC (Cros et al., 2005).

RNAs are transported by interaction with proteins in ribonucleoprotein
complexes or RNPs.
Export Pathways
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Human mRNA nuclear export through the NPC is regulated by the

interaction of proteins, generally termed Nuclear Export Factors (NXF), and
mRNA (Durairaj et al., 2009). Nuclear Export Factor 1 (NXF1/TAP) is the

primary human cellular mRNA nuclear export factor, shuttling mRNAs from
the nucleus to the cytoplasm (Carmody & Wente, 2009) (Figure 5). NXF1 has

low affinity for mRNAs themselves, and interaction is strengthened through
adaptor proteins, termed heterogenous nuclear ribonucleoproteins (hnRNPs)

(Durairaj et al., 2009). Nuclear mRNA export is coupled to mRNA

transcription and processing events such as splicing. UAP56 is a DEAD-box
RNA helicase required for proper mRNA processing and transcriptional
elongation. UAP56 interacts with the tetrameric THO complex; consisting of
Hpr1, Thp2, Tho2, and Mft1. The THO complex is implicated to play an

essential role in transcriptional elongation (Jimeno et al., 2002). Together,
the THO complex and UAP56 are referred to as the transcription/export
(TREX) complex (Durairaj et al., 2009). UAP56 recruits Aly, a hnRNP which

then recruits NXF1 to the mRNA by strengthening NXF1~mRNA interaction.
Aly is displaced by p15, NXFTs cofactor, allowing NXF1/p15 to directly bind

the mRNA (Hautbergue et al., 2008). The NXF1/p15 complex will directly
interact with the Phenylalanine/Glycine repeats in the NPC nucleoporins,

facilitating the nuclear export process (Durairaj et al., 2009). As the mRNP
moves through the NPC, RNA helicase DBP5, which is activated by Gle1, a
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cytoplasmic protein, removes P15 from NXF1, ensuring unidirectional
transport (Stewart, 2007).

In addition to the NXF1 pathway, a small subset of cellular mRNAs,
cellular RNAs, and some viral mRNAs are known to exit the nucleus through

a Ran-GTP dependent mechanism. This involves exportin, nuclear export
transport receptors, binding the RNA along with Ran-GTP. The RNA-

exportin-Ran-GTP complex is translocated to the cytoplasm, where GTP is

hydrolyzed to GDP and the complex dissociates releasing the cargo
(Serpeloni et al., 2011, Bogerd). A cellular mRNA export pathway that is
Ran-GTP dependent is the Crm1 Pathway, which is responsible for the export

of Cyclin D1 mRNA (Carmody & Wente, 2009). Crm1 is not a RNA binding
protein, thus Crm1-mediated export of endogenous mRNAs must occur
through adaptor proteins (Carmody & Wente, 2009). The adaptor protein for
Cyclin D1 export is eukaryotic translation initiation factor 4e (elF4e) (Carmody
& Wente, 2009). An example of a virus that utilizes this pathway is the
Human Immunodeficiency Virus (HIV). In this pathway, Rev, a viral protein,

binds the Rev Responsive Element within the intron of viral mRNAs, and

interacts with Crm1 via a leucine rich NES, facilitating the export of unspliced
and partially spliced viral mRNAs (Cros et al., 2005, Yi et al., 2002). Two
other types of RNAs that are shuttled between the nucleus and cytoplasm in a
Ran-GTP dependent manner are tRNAs and miRNAs. The specific exportins

involved in the transport of miRNA and tRNA are exportin-5 and exportin-t,
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respectively (Figure 5) (Serpeioni et al., 2011). To date no mRNAs have been
shown to export via exportin-t or exportin-5

Influenza Nuclear Trafficking

Influenza vRNP Nuclear Import and Export
Influenza vRNPs are much larger than 50kDa, preventing them from
freely diffusing through the NPC. Therefore, it was hypothesized that at least

one component must contain a NLS. All vRNP proteins (NP, PB1, PB2, and

PA) were found to contain an NLS (Cros et al., 2005, Bullido et al., 2000,
Neumann etal., 1997, Wang etal., 1997, Akkina et al., 1987, Jones et al.,

1986, Nieto et al., 1994). Interestingly, the import of vRNA was demonstrated
to be dependent upon NP protein (O’Neil et al., 1998), and multiple studies

demonstrated that NP contains at least three NLSs, but that only the NLS
found in the N-terminus 13 amino acids of the protein was essential for

nuclear localization (Cros et al., 2005, Bullido et al., 2000, Neumann et al.,
1997, Wang et al., 1997). The vRNPs are translocated to the nucleus

through interaction of vRNP NLSs with karyopherin alpha in a Ran-GTP

dependent manner (Cros et al., 2005, O’Neil 1995).
Once viral replication has been completed, vRNPs must exit the
nucleus to reach the cell membrane, the site of virion assembly and
packaging. Initial investigations implicated M1 in vRNP export, and later it

was found that NS2 bound M1 to export vRNPs from the nucleus (Huang, X
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et al. 2001., Yasuda et al., 1993). NS2 contains a leucine-rich Nuclear Export

Signal (NES), which could functionally play the role that the HIV Rev protein

does and interact with the Crm1 pathway (O’Neil et al., 1998). Deletion of
the NES in NS2 resulted in inhibition of vRNP export (Neumann et al., 2000).

It is believed that the defect is not due to inability of NS2 to interact with

Crm1, but rather the formation of the Crm1-NS2-vRNP-Ran-GTP complex
(Neumann et al., 2000).

Influenza mRNA Nuclear Export
Influenza mRNA nuclear export is less understood. One study had

suggested RdRP proteins bind the mRNA in not only the nucleus but also in
the cytoplasm, and functionally replace the export and translation factor elF4e

(Burgui et al., 2007). However, the RdRP was not found to co-immunopurify
with viral mRNAs in the cytoplasm (Bier et al., 2011). Therefore it is presumed

that influenza mRNAs are associated with host proteins for mRNA nuclear

export. However, there is conflicting data regarding which host pathway is
utilized and the exact host proteins involved (Wang et al., 2008, Read &

Digard, 2010, Satterly et al., 2006).

An investigation by Satterly et. al. into host shut off properties of the
influenza virus found that at 6 hours post infection (h.p.i.) there was NS1-

NXF1 interaction, which led to inhibition of NXF1-mediated export of antiviral

related genes such as interferon. The investigators were led to conclude that

influenza mRNAs must export via Crm1. While they reference a paper to
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defend their conclusion, the citation examined influenza vRNP export

(Neumann et al., 2000). This conclusion is in stark contrast to the results of
Elton et. al., as well as more recent studies, which have found that Crm1
plays no role in Influenza mRNA nuclear export (Elton et al., 2001, Read &

Digard, 2010, Wang et al., 2008). Elton et al, found that blocking of the Crm1
pathway via Leptomycin B (LMB) treatment resulted in reduced virion

production as vRNPs were blocked from exiting the nucleus during assembly.
However, the treatment had no implication upon viral protein expression, thus

no impact upon viral mRNA nuclear export.
A study by Wang et. a(. found that LMB treatment had no effect at all

on PB1, M1, and NA mRNA export. Interestingly, they found that both NS1

and NXF1 co-localize with intronless, intron containing, and fully spliced
influenza mRNAs, confirming the association Satterly et. al. identified.

However, they found that PB1, NA, and M mRNAs co-immunoprecipitate with
NXF1, supporting use of the NXF1 pathway. Unfortunately, the

immunoprecipitation experiment lacked a positive control to detect a
percentage of the total RNA. This control is crucial because during infection

viral transcripts are abundantly produced. Without a positive control
representing 1 to 10% of total RNA, a false interaction could be easily

detected because RT-PCR is a very sensitive method. The mRNA-protein
interaction is dynamic and if 10% of the RNA can be specifically detected in
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the immunoprecipitate, but not the negative control, it is very likely that this

interaction is occurring, thus confirming pathway interaction.
A third study by Read and Digard, found that while inhibition of Crm1

did not alter influenza mRNA export, inhibition of the NXF1 pathway resulted

in nuclear retention of HA, M, and NS but not NP or PB2 mRNAs. These
results further confirm those of Wang et. al. and Elton et. al. in that influenza
mRNA does not utilize Crm1 -mediated export and that at least some
influenza mRNAs utilize Nxf1-mediated export. This report was the first to
identify viral mRNAs utilize neither defined mRNA nuclear export pathway.

Interestingly, they found that PB2 mRNA was not dependent upon NXF1, and

assumed that since PB2 did not appear to be dependent upon NXF1, then
PB1 and PA would not be as well because they are all mRNAs which are

expressed early and encode subunits of the viral RdRP. However, in the
Wang et. Al. investigation, PB1 was found associated with NXF1. Yet, Read

and Digard did not confirm pathway inhibition through analysis of cellular

mRNA nuclear export. Furthermore, they did not look at direct interaction of
Nxf1 with viral mRNAs, a necessary experiment to rule out indirect effects

observed with down regulation of NXF1.
All these investigations into influenza mRNA nuclear export have
another potentially major flaw, in the choice of cell types chosen. According

to August Krough, with each scientific question, there is an ideal model to be
used to answer that question (Krough, 1929). While these studies were all
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performed in kidney cells, either Madin Darby Canine Kidney (MDCK) and/or
293T human kidney embryonic cells as their model, influenza infects the

respiratory tract, thus kidney cells are not the best models. My thesis aimed
to determine which influenza viral mRNAs utilize the Nxf1 mRNA nuclear

export pathways in human lung epithelial cells (A549). To accomplish this I
employed two different methods to inhibit the NXF1 pathway and analyze viral
mRNA export, and directly assess viral mRNA association with Nxf1. Viral
mRNAs whose nuclear export is not mediated by NXF1 must utilize a novel

as yet undiscovered pathway, or another RNA export pathway such as

exportin-t or exportin-5, which do not typically export mRNAs. Identification of
an atypical mRNA nuclear export pathway utilized by influenza to export its
mRNAs out of the nucleus may reveal a novel antiviral target.
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Figure 4. The Nuclear Pore Complex.
Composed of a central transporter channel surrounded by a central
framework. Ring moieties form borders with the nucleus and cytoplasm.
Extending from each ring are eight fibrils, which are free in the cytoplasm and
come together at a distal ring on the nuclear side to from a nuclear basket.
Credit: Koser, J, Maco, B, Aebi, U, and Fahrenkrog, B, (2005). The Nuclear
Pore Complex Becomes Alive: New Insights into Its Dynamics and
Involvement in Different Cellular Processes. Atlas of Genetics and
Cytogenetics in Oncology and Haematology.
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Figure 5. Known Cellular mRNA Nuclear Export Pathways.
The majority of cellular mRNAs exit the nucleus in a NXF1 dependent
manner. tRNA and miRNA exit in a Ran-GTP dependent manner via
exportin-t and exportin-5 respectively. A small subset of mRNAs as well as
rRNAs exit in a Ran-GTP dependent manner using Crm1.
Credit: Kohler,A and Hunt, E, (2007). Exporting RNA From the Nucleus to the
Cytoplasm. Nature, 8, 761-773.
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CHAPTER THREE
SELECTIVE INHIBITION OF NUCLEAR EXPORT PATHWAYS

Background

To examine the pathways used by influenza viral mRNAs to exit the
nucleus, 1 used two different methods to block the Nxf1 mRNA nuclear export

pathway. The first method was by expression of a dominant negative NXF1
(DN-NXF1) variant lacking a nuclear export signal, leading to inhibition of the

NXF1 pathway (Kang & Cullen, 1999). The expression of this protein allows
NXF1 to bind mRNA but does not allow the export, leading to pathway
inhibition (Kang & Cullen, 1999). The second method was by expression of

siRNAs targeting specific export factors. Transfection with siRNA specific to
NXF1 and UAP56 mRNA inhibits expression of both Nxf1 and UAP56, and
inhibition of both nuclear export pathways. Treatment with siRNA would be

expected to completely inhibit the pathway, because siRNA is an efficient

method to down regulate target gene expression, whereas expression of DNNXF1 may not cause complete inhibition unless expression of the dominant

negative form was to exceed that of endogenous.
To confirm inhibition of each pathway, host mRNA nuclear export was

assessed. Beta-actin is known to exit the nucleus via the NXF1 pathway thus
analysis of this host mRNA will confirm pathway inhibition (Carmody & Wente,
2009, Huang, Y et al., 2004). I primarily examined A549 cells. However, in
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order to confirm and expand upon previously published work (Read & Digard,

2010), I also examined nuclear export in 293T cells.

Results
Plasmid DNA encoding DN-NXF1, or vector alone (CMV) with eGFP to
monitor transfection efficiency, were transfected into 293T or A549 cells. The

cells were allowed to proliferate for 48 hours before one set was infected with

Influenza A Udorn at high multiplicity of infection (MOI). At 3.5 hours post

infection (hpi), cytoplasmic and nuclear RNAs and proteins were isolated.
The clarity of the cytoplasmic/nuclear fractionations was assessed via SDS-

PAGE and western blotting techniques (Figure 6 & 7). Both 293T and A549
cellular fractionation was successful, as TAT-SF1 and SP1, nuclear proteins,

are solely observed in nuclear samples, while Tubulin and Hsp90,

cytoplasmic proteins, are only observed in cytoplasmic fractions.
Total polyadenylated RNA was reverse transcribed into cDNAs using

oligo dT. Influenza virus results in host shut off of gene expression and thus
the uninfected samples were assessed for inhibition of nuclear export

pathway using PCR with gene specific primers to analyze host mRNA nuclear
export. Beta-actin is known to exit the nucleus via the NXF1 pathway (Huang,

Y et al., 2004). Analysis of Beta-actin mRNAs confirmed that expression of

the dominant negative proteins resulted in NXF1 pathway inhibition (Figure

8).
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RNA from the cytoplasm of infected cells was assessed using RT with
oligo dT and PCR with gene specific primers. With 293T cells, semi-

quantitative PCR reveals a clear decrease in cytoplasmic HA, NA, M1, and
NS1 but no change in NP, PB2 mRNAs (Figure 9). Interestingly, cytoplasmic

NS2 mRNA increased with DN treatment (Figure 9). Quantitative PCR allows

us to determine the relative inhibition of different viral mRNAs. Results
showed cytoplasmic NA, HA, M, and NS mRNAs in the DN treated cells were

26%, 66%, 82%, and 92% of the control cells, with t-tests indicating all
differences to be statistically significant (Figures 12 & 13). However, total

cytoplasmic NP and PB2 mRNAs were found to be 102% and 107% of the
control cells, with t-tests indicating no significant difference between the two
treatment groups. Our results confirm Read and Digard’s conclusions that
the nuclear export of NP and polymerase mRNAs is not mediated by NXF1 in

293T cells.

In A549 cells, semi-quantitative PCR reveals a clear decrease in

cytoplasmic NP, NA, and HA, but no detectable decrease in cytoplasmic PA,
PB1 or PB2 mRNAs when DN-NXF1 is expressed (Figures 10 & 11). qPCR
results show the total cytoplasmic HA, NP, NA, M, and NS mRNAs in the DN
treated cells to be 87%, 70%, 27%, 70%, and 84% of the control cells, with ttests indicating that all differences were statistically significant (Figures 12 &

13). Conversely, total cytoplasmic PB2 mRNA was found to be 97.22% of the
control cells, with t-test indicating no significant difference between the two
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treatment groups. Our results in A549 cells reveal cell type difference for NP

mRNA export compared to 293T cells.
The second method used to target the major nuclear export pathways
was through siRNA to target NXF1 and another host export factor, UAP56.

A549 cells were transfected with siRNA targeting Nxf1, UAP56, or scrambled

control for 48hrs. UAP56 is a DEAD box RNA helicase thought to be

upstream of both Nxf1 and Crm1 mediated mRNA nuclear export (Carmody &
Wente, 2009). Cells were either mock or infected for 3 hours, and then
proteins and RNA from the cytoplasm and nucleus were collected. NXF1 and

UAP56 protein expression were successfully down regulated by their
respective siRNA treatment in A549 cells (Figure 14).

Down-regulation of NXF1 led to a decrease in cytoplasmic Beta-actin
mRNAs (Figure 15). We further found that all influenza mRNAs examined

were at decreased levels in the cytoplasm, including NP and PA mRNAs

(Figure 16). This differed from the results obtained with expression of DNNxf1 to inhibit Nxf1-mediated nuclear export, and led us to further analyze

nuclear RNA. We found there was a decrease in influenza nuclear mRNA in
cells with NXF1 down-regulated (Figure 17), indicating indirect inhibition of

viral transcription. Thus any changes observed in influenza mRNA export
cannot be claimed as due to inhibition of the nuclear export pathway, but
rather due to indirect effects on viral mRNA synthesis. Therefore we did not

further pursue inhibition of NXF1 by siRNA.
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Down-regulation of UAP56 led to no decrease in cytoplasmic Beta
actin mRNAs (Figure 15). This is likely due to the fact that there are other
RNA helicases, which have overlapping functions, such as the highly similar
URH49 (Pryor et al., 2004). However, down-regulation of UAP56 led to a
decrease in cytoplasmic Cyclin D1 mRNAs which is expected because

UAP56 is also implicated upstream of the Crm1 nuclear export pathway
(Figure 15). We found that the down-regulation of UAP56 led to no changes
in. cytoplasmic influenza mRNA levels (Figure 16). This agrees with data in

kidney cells that Crm1 is likely not involved with influenza A viral mRNA
nuclear export.

In summary, siRNA against UAP56 suggests that UAP56 is essential
for the Crm1 pathway and confirms that influenza does not utilize this

pathway. siRNA against Nxf1 lead to indirect inhibition of viral mRNA

expression and therefore we could not use this approach to assess the role of
Nxf1 in viral mRNA nuclear export. Our experiments with DN-Nxf1 expression

were more fruitful and revealed a cell type difference between NP mRNA
export in 293T and A549 cells.
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Figure 6. Western Blot of Mock Infected and Infected 293T Kidney Cells.
293T cells were transfected with plasmids expressing dominant negative Nxf1
or vector control. At 48 hours post transfection, cells were infected with
Influenza A Udorn at high multiplicity of infection or mock infected. At 3 hours
post infection, cells were collected and cytoplasmic and nuclear RNA was
isolated and analyzed by western analysis, a-tubulin was used to detect
tubulin, a protein localized to the cytoplasm. a-TAT-SF1 was used to detect
TAT-SF1, a protein localized to the nucleus.
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Figure 7. Western Blot of Mock Infected and Infected A549 Lung Cells.
A549 cells were transfected with plasmids expressing dominant negative Nxf1
or vector control. At 48 hours post transfection, cells were infected with
Influenza A Udorn at high multiplicity of infection or mock infected. At 3 hours
post infection, cells were collected and cytoplasmic and nuclear RNA was
isolated and analyzed by western analysis. a-HSP90 was used to detect
HSP90, a protein localized to the cytoplasm. a-SP1 was used to detect SP1,
a protein localized to the nucleus.
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Figure 8. RT-PCR of Host Beta-Actin mRNA in 293T Kidney and A549 Lung

Mock infected Cells.
A549 and 293T cells were transfected with plasmid expressing Dn-Nxfl(Dn)
or vector as control. At 48 hours post transfection, cells were infected with
Influenza A Udorn at high multiplicity of infection or mock infected. At 3 hours
post infection, cells were collected and cytoplasmic and nuclear RNA was
isolated, quantified, and equal concentrations were subjected to reverse
transcription with oligo dT and PCR with gene specific primers as indicated.
Host beta actin mRNAs were decreased in the cytoplasm of both A549 and
293T cells expressing dominant negative Nxf1, confirming inhibition of Nxf1mediated mRNA nuclear export.
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Figure 9. RT-PCR of Influenza Genes in 293T Kidney Cells.

293T cells were transfected with plasmid expressing Dn-Nxfl(Dn) or vector
as control. At 48 hours post transfection, cells were infected with Influenza A
Udorn at high multiplicity of infection or mock infected. At 3 hours post
infection, cells were collected and cytoplasmic and nuclear RNA was isolated,
quantified, and equal concentrations were subjected to reverse transcription
with oligo dT and PCR with gene specific primers as indicated. Influenza HA
and NS1 mRNAs were found in decreased amounts in the cytoplasm of cells
expressing Dn. Influenza NP and NS2 mRNAs were not found in decreased
amounts.
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Figure 10. RT-PCR of Influenza Genes in A549 Lung Cells.
A549 cells were transfected with plasmid expressing Dn-Nxfl(Dn) or vector
as control. At 48 hours post transfection, cells were infected with Influenza A
Udorn at high multiplicity of infection or mock infected. At 3 hours post
infection, cells were collected and cytoplasmic and nuclear RNA was isolated,
quantified, and equal concentrations were subjected to reverse transcription
with oligo dT and PCR with gene specific primers as indicated. PA, PB1, and
PB2 mRNAs were not found in decreased amounts in the cytoplasm of cells
expressing Dn. However, NP mRNA was.
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Figure 11. RT-PCR of Influenza NP in A549 Lung Cells.

A549 cells were transfected with plasmid expressing Dn-Nxf1 (Dn) or vector
as control. At 48 hours post transfection, cells were infected with Influenza A
Udorn at high multiplicity of infection or mock infected. At 3 hours post
infection, cells were collected and cytoplasmic and nuclear RNA was isolated,
quantified, and equal concentrations were subjected to reverse transcription
with oligo dT and PCR with gene specific primers as indicated. Duplicate
trials show NP mRNAs found in lower amounts in the cytoplasm of cells
expressing Dn.
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Figure 12. qPCR of Influenza Genes in A549 Lung and 293T Kidney Cells.
A549 and 293T cells were transfected with plasmid expressing Dn-Nxfl(Dn)
or vector as control. At 48 hours post transfection, cells were infected with
Influenza A Udorn at high multiplicity of infection or mock infected. At 3 hours
post infection, cells were collected and cytoplasmic and nuclear RNA was
isolated, quantified, and equal concentrations were subjected to reverse
transcription with oligo dT and qPCR with gene specific primers as indicated.
A) 293T cells, B) A549 cells. Influenza HA mRNAs show a defect in
cytoplasmic levels when dominant negative Nxf1 is expressed in both 293T
and A549 cells. PB2 mRNAs show no defect in cytoplasmic levels in both
293T and A549 cells when dominant negative Nxf1 is expressed. NP mRNA
shows a defect in cytoplasmic levels in A549 cells expressing dominant
negative Nxf1, but not in 293T cells. * (P-Value <.O5)
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Figure 13. qPCR of Influenza Genes in A549 Lung and 293T Kidney Cells.
A549 and 293T cells were transfected with plasmid expressing Dn-Nxfl(Dn)
or vector as control. At 48 hours post transfection, cells were infected with
Influenza A Udorn at high multiplicity of infection or mock infected. At 3 hours
post infection, cells were collected and cytoplasmic and nuclear RNA was
isolated, quantified, and equal concentrations were subjected to reverse
transcription with oligo dT and qPCR with gene specific primers as indicated.
A) 293T cells, B) A549 cells. Influenza NA, M, and NS mRNAs show a defect
in cytoplasmic levels when dominant negative Nxf1 is expressed in both 293T
and A549 cells. NP mRNA shows a defect in cytoplasmic levels in A549 cells
expressing dominant negative Nxf1, but not in 293T cells. * (P-Value <.O5).
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Figure 14. Western Blot of Cells Treated with siRNA Against NXFT and
UAP56 in A549 Lung Cells.
A549 cells were transfected with 2nM siRNA targeting Nxf1, UAP56, or
scramble as control. At 48 hours post transfection cells were infected with
Influenza A Udorn at high multiplicity of infection. At 3 hours post infection,
cells were collected and nuclear and cytoplasmic extracts were prepared.
RNA was isolated, quantified, and equal concentrations were subjected to
reverse transcription with oligo dT and PCR with gene specific primers as
indicated. Western blot confirms down-regulation of target genes. Hsp90 is a
cytoplasmic localized protein and while Nxf1 is nuclear localized and UAP56
is present in both cytoplasm and nucleus.
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Figure 15. RT-PCR of Host Genes in Cytoplasmic Fraction of NXF1 and
UAP56 siRNA Treated A549 Lung Cells.

A549 cells were transfected with 2nM siRNA targeting Nxf1, UAP56, or
scramble as control. At 48 hours post transfection cells were infected with
Influenza A Udorn at high multiplicity of infection (Flu +) or mock infected
(Flu -). At 3 hours post infection, cells were collected and nuclear and
cytoplasmic extracts were prepared. RNA was isolated, quantified, and equal
concentrations were subjected to reverse transcription with oligo dT and PCR
with gene specific primers as indicated.
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Figure 16. RT-PCR of Infuenza Genes in Cytoplasmic Fraction of NXF1 and
UAP56 siRNA Treated A549 Lung Cells.
A549 cells were transfected with 2nM siRNA targeting Nxf1, UAP56, or
scramble as control. At 48 hours post transfection cells were infected with
Influenza A Udom at high multiplicity of infection (Flu +) or mock infected (Flu
-). At 3 hours post infection, cells were collected and nuclear and cytoplasmic
extracts were prepared. RNA was isolated, quantified, and equal
concentrations were subjected to reverse transcription with oligo dT and PCR
with gene specific primers as indicated. Down-regulation of Nxf1 leads to
decreased influenza NP, PA, and M mRNA in cytoplasm.
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Figure 17. RT-PCR of Infuenza Genes in Nuclear Fraction of NXF1 and
UAP56 siRNA Treated A549 Lung Cells.

A549 cells were transfected with 2nM siRNA targeting Nxf1, UAP56, or
scramble as control. At 48 hours post transfection cells were infected with
Influenza A Udorn at high multiplicity of infection (Flu +) or mock infected (Flu
-). At 3 hours post infection, cells were collected and nuclear and cytoplasmic
extracts were prepared. RNA was isolated, quantified, and equal
concentrations were subjected to reverse transcription with oligo dT and PCR
with gene specific primers as indicated. Down-regulation of Nxf1 leads to
decreased influenza NP, PA, and M mRNA in nucleus.
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CHAPTER FOUR
INTERACTION WITH NUCLEAR EXPORT FACTOR NXF1

Background
Inhibition of mRNA nuclear export through either expression of a

dominant negative protein or siRNA treatment will lead to the inhibition of the
export and expression of many genes. Some of these genes may encode
proteins involved in the transcription and/or export of influenza mRNAs, thus

inhibiting influenza mRNA nuclear export via indirect effects. Several host
factors, such as Hsp-90 and hCLE have been shown to play a role in the

transcriptional activity of the influenza virus (Huarte et al., 2001, Naito et al.,

2007). NXF1 is responsible for the nuclear export of the majority of cellular
mRNAs. Complete shutdown of this pathway, as with siRNA, likely prevents
the export of a host factor necessary for viral replication. Our siRNA results
(Chapter 3) support this idea. Additionally, a previous investigation by
another lab, found significantly decreased cell viability with siRNA treatment

for NXF1 at 48 hours post transfection (Johnson et al., 2009).
In order to alleviate concerns over indirect effects, interaction of

Influenza mRNAs with the NXF1 pathway should be confirmed. If influenza
mRNAs are to utilize the NXF1 pathway, they must be associated with the

NXF1 protein while undergoing the export process.
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Results

Plasmid DNA encoding FLAG-Nxf1 or Flag alone (vector) were
transfected into A549 cells. At 48 hours post transfection, the cells were

infected at a high MOI for 7 hours with Influenza A Udorn. Total protein was
isolated and immunopurified with anti-FLAG antibody under conditions to limit

disrupting interactions with influenza mRNAs. The FLAG alone extract serves
as negative control. Pull down of Nxf1 was verified via western blot with anti-

FLAG (Figure 18). Total and Nxf1 associated mRNAs were reverse
transcribed into cDNAs with oligo dT and analyzed via gene specific PCR for

identification of influenza mRNAs associated with FLAG -Nxf1. The positive

control was 10% of total RNA. NP, M, NS, and HA mRNAs were found to coimmunopurify with the NXF1 protein but not the vector, confirming specific

interaction of Nxf1 with the viral mRNAs (Figure 20). The interaction of NP
mRNA with FLAG-Nxf1 in A549 has been replicated more than five times.
Approximately 13% of the total HA mRNAs were found to be associated with

FLAG-Nxf1 via qPCR (Data not shown). Since interaction with the export
factor is dynamic, it was expected that only a fraction of the viral mRNAs
would be found associated with Nxf1. No PB1, PB2, or PA mRNAs were

found associated with NXF1 (Figure 19). These negative results were

confirmed with each experiment that showed a positive pull down of NP
mRNA. Our results confirm the dependence of NP mRNA on the NXF1 ,

pathway in A549 lung cells, the subject of the cell type difference.
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IP

SLip

total

IP

sup

total

Flag-Nxf1

Flag-Vector

Flag-Nxf1

Figure 18. Western Blot of Co-Immunopurification Samples.
A549 cells were transfected with plasmid to express FLAG-Nxf1 or FLAGvector as negative control. At 48 hours post transfection, cells were infected
with Influenza A Udorn at high multiplicity of infection. At 7 hours post
infection, total cell extracts were prepared and subject to immunopurification
with anti-FLAG antibody and analyzed by western analysis. a-NXF1 was
used to detect the FLAG tagged NXF1 protein. FLAG-Nxf1 was found in the
samples expressing FLAG-Nxf1, confirming successful Coimmunopurification.
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Sup

Flag-Vector

Sup

IP

Flag-Nxfl

Figure 19. RT-PCR of Influenza Polymerase mRNAs Co-lmmunopurified with

FLAG-NXF1 and FLAG-Vector.
A549 cells were transfected wth plasmid to express FLAG-Nxf1 or FLAGvector as negative control. At 48 hours post transfection, cells were infected
with Influenza A Udorn at high multiplicity of infection. At 7 hours post
infection, total cell extracts were prepared and subject to immunopurification
with anti-FLAG antibody. RNA from both the immunopurified complexes (IP)
and total cell extracts were quantified and equal concentrations subject to
reverse transcription using olido dT and PCR with influenza gene specific
primers as indicated. 10% of the RNA from the total RNA samples is used for
PCR as positive control. PA, PB1, and PB2 mRNAs were not found
associated with FLAG-Nxf1.
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FLAG-Vector

FLAG-NXF1

Figure 20. RT-PCR of Influenza Polymerase mRNAs Co-Immunopurified with

FLAG-NXF1 and FLAG-Vector.
A549 cells were transfected with plasmid to express FLAG-Nxf1 or FLAGvector as negative control. At 48 hours post transfection, cells were infected
with Influenza A-Udorn at high multiplicity of infection. At 7 hours post
infection, total cell extracts were prepared and subject to immunopurification
with anti-FLAG antibody. RNA from both the immunopurified complexes (IP)
and total cell extracts were quantified and equal concentrations subject to
reverse transcription using olido dT and PCR with influenza gene specific
primers as indicated. Equal concentration of RNA from the total RNA samples
is used for PCR as positive control. NP, HA, NS1, NS2, M1, M2, and NA
mRNAs specifically immunopurify with anti-flag antibody when FLAG-Nxf1 is
expressed but not in FLAG-vector control.
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-------------- ___
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Figure 21. Conclusion Table.
Table summary of DN-NXF1 and co-lmmunopurification experiments as well
as Read and Digard’s results.
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CHAPTER FIVE
MATERIALS AND METHODS

Cells

293T (Human embryonic kidney cells) and A549 (Human lung
epithelial) cells were purchased from ATCC American tissue culture collection

and maintained at 37°C with 5% CO2 in DMEM with 10% FBS.

Plasmids

Plasmids encoding DN Nxf1 was provided by B. Cullen and plasmid encoding
FLAG-NXF1 was provided .by J. Steitz (Steitz, Kang & Cullen, 1999). DNA
was purified using QIAGEN maxi prep kit per manufacturers protocol.

DNA Transfection
I

293T or A549 cells were grown to approximately 70% confluency in

100 mm dishes. The pcDNA plasmids encoding FLAG-NXF1 (10 pg) and
FLAG-Vector/eGFP (1 pg), or DN-Nxf1 (10 pg) and CMV (9 pg) with eGFP
(1pg) was transfected into cells using Mirus transfection reagent at a ratio of
1:3 (293T cells) or 1:2 (A549 cells), DNA to reagent as specified in

manufacturers protocol. eGFP was used to monitor transfection efficiency. 4
8 hrs post transfection one set was mock infected and the other infected at a
high MOI (2-5 MOI). Cells were collected 3.5 hrs post infection in Pathway
inhibition experiments, and 6.5 hrs post infection in Co-Immunopurification

experiments.
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SiRNA Transfection

A549 cells were transfected with 2nM SMART pool siRNA
(Dharmacon) targeting Nxf1, UAP56, or scramble as control using

Dharmacon transfection reagent per manufacturers protocol. At 48 hours
post transfection cells were infected with Influenza A Udorn at high multiplicity
of infection (Flu +) or mock infected (Flu -). At 3 hours post infection, cells

were collected.

Cytoplasmic/Nuclear RNA and Protein Isolation

Cells pellet was washed in 5X volume of cell pellet with Reticulate

Standard Buffer (RSB: 10mM Tris HCI pH7.5, 10mM KCI, 1.5mM MgC!2) with
protease and RNase inhibitors. Cells were then re-suspended in RSB at 10X

the volume of the cell pellet and incubated on ice for 10 minutes. NP-40 was
added to a final concentration of 0.2% to disrupt plasma membranes. Visual

inspection of the cells before and after addition of NP-40 ensured burst

plasma membranes and intact nuclei. Nuclei were pelleted by centrifugation
at 300xg for 8 minutes at 4°C. The cytoplasmic extract was collected and the
nuclear pellet was re-suspended in Dignam Buffer C without glycerol (20mM
HEPES pH 7.9, 0.42M NaCI, 1.5mM MgCI2, 0.2mM EDTA), plus protease and
RNase inhibitors, to release nuclear molecules. Both nuclear and

cytoplasmic extracts were clarified from debris by high-speed centrifugation
for 10 minutes at4°C. An equal amount of 20mM HEPES pH 7.9, 0.2mM
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EDTA was added to the nuclear extract to reduce the total NaCI and MgCl2
concentrations. Some volume was saved for protein analysis. Equal volume

of Phenol/Chloroform/lsoamyl alcohol (25:24:1) is added to the cytoplasmic

and nuclear fractions. Sample was vortexed 4 times for 10 seconds and
placed on ice in between. Samples were centrifuged at 13,000 RPM for 10

minutes at4°C. Aqueous layer was collected and 0.5 volume NH4OAc (7.5
M) and 2X volume 100% EtOH was added and RNA was allowed to

precipitate overnight at -80°C. Samples were centrifuged at 13,000 RPM for
20 minutes at 4°C. Pellet was washed in 75% EtOH and centrifuged at

13,000 RPM for 5 minutes at 4°C. EtOH was removed and pellet was

allowed to air dry for 10 minutes and resuspended in 10 mM Tris in DEPC
H2O.

SDS-PAGE and Western Blot

Protein extracts were separated by SDS-10% PAGE. Proteins were
transferred to nitrocellulose using Fisher semi-dry blot apparatus and probed
with primary and HRP-conjugated secondary antibodies as indicated. Pierce

ECL reagents were used to detect HRP conjugated secondary antibody.
Blots were developed using the Chemi-Hi setting on the ChemiDoc™ XRS
(BioRad) system and digital images were obtained using Quantity One

software.
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Antibodies

a-TAT-SF1, a-Tubulin, a-SPI, a-HSP90, aNXF1, and a-FLAG were

purchased from Abeam and used per manufacturers instructions. Secondary
HRP coupled a-Mouse and a-Rabbit were purchased from Pierce and used
per manufacturer’s instructions.

RT-PCR

RNA was first treated with RNase-free DNase (Promega) to degrade any
contaminating DNA. 1 pg cytoplasmic and .5pg nuclear RNA were subject to

reverse transcription using Promega reverse transcription system per

manufacturer’s protocol with oligo dT as primer.

PCR Primers
Gene specific primers for semi-quantitative PCR are as follows:

For NP (5’ NP- CCAGAAGAAGTGTCCTTCCG, 3’NPCGTACTCCTCTGCATTGTCTCC), Beta-Actin (E3FbGGACGACATGGAGAAATCTGGCACC, E4RbGCGGAACCGCTCATTGCCAATGG), PB1 (5’ PB1CCCCTGAATCCATTTGTCAGCCATA, 3’PB1ATGAAGGACAAGCTAAATTG),

HA (5’HA- GCTCTGGAGAACCAACATACAA, 3’HAACAAGGGTGTTTTTAATTACTAATA), NS (5’ NS1/NS2-
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GGATTCCAACACTGTG, 3’NS2- GCCATCTTATCTCTTCG), M (5’MGCCTTCTGACCGAGGTCG, 3’M- CCCAATGATACTCGCAGC), PB2 (5’
PB2- CCACCCAGATAATAAAGCTTCTCCCC, 3’PB2-

GTCAGTAAGTATGCTAGAGTCCCG), PA (5’PAATGACCAAAGAGTTTTTTGAGAATA, 3’PA-

GTATGGATAGCAAATAGTAGCATTG), and Cyclin D1 (5’UTRCyclin-

CGGTCACCTAGCAAGCTGCC, 3’UTRCyclinCAGGACAGACTCCGCTGTGA).

Immunopurification

Total protein extracts were incubated with a-FLAG antibody (Stratagene)
(1:50) and protease inhibitors for 1 hour at 4° C.' Extracts were then

incubated with PA/G sepharose beads with protease inhibitors at 4° C
overnight. The samples were then spun for 8 seconds at 13,000 RPM at 4°
C. Supernatant was collected. Beads were washed 3 times in 1 mL
sonication buffer with RNase inhibitors. With each wash samples were then

centrifuged for 8 seconds at 13,000 RPM at 4° C. 1/3 of beads from last
wash is saved for protein analysis, and 2/3 of supernatant is saved for RNA

isolation.

RNA Isolation
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Equal volume (RNA containing resuspended beads) of
Phenol/Chloroform/lsoamyl alcohol (25:24:1) is added to the resuspended
bead immunopurification sample and total extract (for the positive control).
Sample was vortexed 4 times for 10 seconds and placed on ice in between.

Samples were centrifuged at 13,000 RPM for 10 minutes at 4°C. Aqueous

layer was collected and 0.5 volume NH4OAC (7.5 M) and 2X volume 100%

EtOH was added and RNA was allowed to precipitate overnight at -80°C.
Samples were centrifuged at 13,000 RPM for 20 minutes at 4°C. Pellet was
washed in 75% EtOH and centrifuged at 13,000 RPM for 5 minutes at 4°C.

EtOH was removed and pellet was allowed to air dry for 10 minutes and
resuspended in 10 mM Tris in DEPC H2O.

Total Protein Isolation

Cell pellets were resuspended in 1 mL of Sonication Buffer (100mM

Tris HCI pH 7.5, 100mM NaCI, 2.5 mM MgCI2, 0.5% Triton x-100) with

protease and RNase inhibitors. Cells were lysed using Fisher Scientific Sonic
Dismembrator for 30 pulses at 30%, output 3-4. Sonicated materials were

loaded onto a 30% sucrose cushion (30% Sucrose, 10 mM Tris HCI pH 7.5,

100 mM NaCI, 2.5 mM MgCl2) and centrifuged at 4000 RPM, for 15 minutes at
4°C to clarify total protein extract.

Quantitative PCR: Protocol and Primers
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Quantitative PCR reactions, were run in the Applied Biosystems
StepOnePlus Real Time PCR system using Sybr Green Master mix (Applied

Biosystems)
Gene specific primers PCR are as follows:
NA(Forward-TGTGTGCTCAGGGCTTGTTG, ReverseCTCCGTGATTCCCTTTCTCATT), HA(ForwardACTGAAGTCAGGATACAAAGACTGGAT, Reverse-

CCCCAGCAAAACAACACAAA), NP(ForwardGTGTGCAACCTGCATTTTCTGT, ReverseTCTGAGGTTCTTCCCTCCGTATT), PA(ForwardGGACAAATGGAACATCAAAGATTAAA, Reverse-

CAGAAGACTCGGCTTCAATCATG), PB1 (ForwardGGGAAAGGATACATGTTCGAAAGT, ReverseACTTTAGGTCAATGCTTGCTAGCA), PB2(Forward-

AATAAAGCTTCTCCCCTTTGCA, Reverse-

CCCTCACATTCACAGTCAATGAA)

Statistical Analysis of QPCR Data

Raw CT values were analyzed in Microsoft Excel using the ACt/ACt
formula of 2ACTaverage Control sample/2A

CTaverage Treated sample-

TWO

Tailed T-Test

was conducted in Microsoft Excel, and any p value greater than .05 was

judged to be an insignificant difference. Error bars were obtained by
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calculating the standard deviation of the sample set divided by the square
root of the sample set size
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CHAPTER SIX
DISCUSSION AND FUTURE RESEARCH

Summary

A critical step for Influenza A infection is the localization of the vRNPs

to the host cell nucleus, the site of virus replication and transcription (Cros et
al., 2005, Resa- Infante, Martin-Benito et al., 2001) (Figure 2). Once the viral

transcripts are expressed, M and NS can undergo splicing, and all the
mRNAs must exit the nucleus in order to be translated in the cytoplasm. The

major structure involved in nuclear trafficking is an assembly of nucleoporins
located within the nuclear envelope. This assembly of nucleoporins is termed

the Nuclear Pore Complex (NPC) (Durairaj et al., 2009). Molecules with a
molecular weight less than 40,000 to 50,000 are understood to freely diffuse

through the NPC. However, larger molecules require a nuclear localization
signal (NLS) or a nuclear export signal (NES). These epitopes allow proteins

to be actively transported into or out of the nucleus, through interaction with
components of the NPC (Cros et al., 2005). RNAs are transported by

interaction with proteins in ribonucleoprotein complexes or RNPs.

Human mRNA nuclear export through the NPC is regulated by the
interaction of proteins, generally termed Nuclear Export Factors (NXF), and
mRNA (Durairaj et al., 2009). Nuclear Export Factor 1 (NXF1/TAP) is the

primary human cellular mRNA nuclear export factor, shuttling mRNAs from
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the nucleus to the cytoplasm (Carmody & Wente, 2009) (Figure 5). It is
presumed that influenza mRNAs are associated with host proteins for mRNA

nuclear export. However, there is conflicting data regarding which host

pathway is utilized and the exact host proteins involved (Wang et al., 2008,

Read & Digard, 2010, Satterly et al., 2006).
The Satterly study and the Wang study both showed that influenza

NS1 protein interacts with host Nxf1 in kidney cells. Our lab has also

confirmed this interaction in A549 cells (Data not shown). While the Satterly
lab concluded the interaction with NS1 was to inhibit host mRNA nuclear

export, the Wang paper concluded that NS1 may be involved in viral mRNA
nuclear export because their study suggested some viral mRNAs export

through Nxf1. The role of the NS1-Nxf1 interaction remains undefined, but it is

clear that the Nxf1 nuclear export is not inhibited during infection as the Wang
study, the Read and Digard study, and my own research conclude many viral
mRNAs depend on expression of Nxf1 for export from the nucleus.

The Read and Digard study was the first to show evidence that not all

viral mRNAs utilize Nxf1. Coupled with evidence from multiple studies
showing Crm1 is not involved in viral mRNA nuclear export, these results

indicate that some viral mRNAs utilize an undefined mRNA nuclear export
pathway. Our data make a significant contribution to the published literature.

First, we confirm that Crm1 is not utilized for viral mRNA export, as
exemplified by inhibition of the upstream protein, UAP56, which specifically
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inhibits cyclin D1 mRNA nuclear export but no viral mRNAs. Second, we

confirm that some viral mRNAs utilize Nxfl and others do not rely on either
Nxfl or Crm1 (as seen by inhibition of UAP56) (Figures 9,10, 12,13, 16,17, 19

& 20). This confirms that some viral mRNAs utilize an as yet undefined

nuclear mRNA export pathway and identification of this pathway may reveal

potential novel antiviral targets. Importantly, our data reveal a cell type

difference in use of Nxfl. This finding has implications for interpretation of
previous studies, as kidney cells may not be the best model for studying the
influenza A virus.

This research is important is because it adds to our understanding of
the influenza virus life cycle and supports the existence of an undefined
mRNA nuclear export pathway. Identification of this atypical pathway utilized
by influenza may reveal new insights into cellular biology and provide novel

antiviral targets to fight influenza.

Discussion

Most pertinent to this study is the Read and Digard study which found
that the siRNA inhibition of the NXF1 pathway, in 293T cells, resulted in
nuclear retention of HA, M, and NS but not NP or PB2 mRNAs (Read &
Digard, 2010). Additionally, Read and Digard and Wang et. al. both concluded

that the inhibition of Crm1 did not alter influenza mRNA export (Wang et al.,
2008, Read & Digard, 2010). According to August Krough, a Nobel laureate
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physiologist, with each scientific question, there is an ideal model to be used

to answer that question (Krough, 1929). Previous studies investigating the
use of the host mRNA nuclear export pathways by'the influenza virus have

used 293T and MDCK cells as the model of choice. Influenza infects the
upper respiratory tract, and thus kidney cells may not be the best choice for
characterizing influenza infection.

It is also difficult to understand how Read and Digard were able to
obtain results using siRNA to inhibit Nxf1. Using identical conditions, we

found that influenza viral mRNA expression is inhibited under this condition.

siRNA is an extremely efficient method to down regulate target gene
expression, resulting in nearly complete inhibition of the pathway. NXF1 is
responsible for the nuclear export of the majority of cellular mRNAs.
Complete shutdown of this pathway, as with siRNA, likely prevents the export

of a host factor necessary for viral replication. Our findings echo a previous

investigation, which found significantly decreased cell viability with siRNA
treatment for NXF1 at 48 hours post transfection (Johnson et al., 2009).

Previous studies in 293T cells have shown that PB2 and NP do not
exhibit dependence upon the Nxf1 pathway, but that HA, M, and NS do (Read

& Digard, 2010). DN experiments in 293T cells not only confirmed previous
findings, but expanded upon them by showing that not only was M, NS, and

HA mRNA dependent upon Nxf1, but NA mRNA was as well. In agreement
with Read and Digard, NP and PB2 mRNAs were not dependent upon Nxf1.
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Interestingly, when we examine nuclear export in A549 lung cells, we see that
not only are NA and HA mRNAs dependent upon Nxf1 but so is NP mRNA.

These results reveal an important difference betwe’en the two cell types. This

is the first report of a cell type difference in influenza A mRNA nuclear export.
Our method of inhibition varied from the siRNA approach used in the
Read and Digard study, and we replicated their results, in the same cell type

(293T cells). While our methods varied, our conclusions were the same.
Since inhibition of the Nxf1 pathway in DN experiments is dependent upon

efficiency of transfection, as well as the fraction of DN-Nxf1 compared to wild
type Nxf1, the range of inhibition can vary from experiment to experiment.
Despite this, the pattern remains the same, and we do not see variance in

which mRNAs show dependence upon Nxf1 export.

If influenza mRNAs are to utilize the NXF1 pathway, it is assumed they
must be associated with the NXF1 protein while undergoing the export
process. Read and Digard did not confirm this interaction, but the Wang

study did, and concluded that NA, M and PB1 mRNAs co-immunopurified with
NXF1. In A549 lung cells, NP, NA, HA, M, and NS mRNAs all showed

dependence upon the Nxf1 pathway in DN experiments and thus we should
find them associated with the Nxf1 protein. This is indeed what we find. Also
confirming previous findings, as well as our own experiments, the polymerase

(PB1, PB2, and PA) mRNAs were not found to co-immunopurify with FLAGNxf1, and therefore we conclude not dependent upon the Nxf1 pathway. The
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only difference is where we do pull down NS2 mRNA with the NXF1 protein,
but do not find NS2 mRNA to be dependent upon NXF1, in 293T kidney cells,
the DN-NXF1 experiments. This leaves the verdict on NS mRNA nuclear

export to be determined.
Taken as a whole, the DN and co-immunopurification experiments

provide compelling evidence that cell type differences exist and should be
taken into consideration when interpreting studies examining influenza
infection dynamics. Knowing that influenza infects the respiratory tract and

armed with knowledge that there is a cell type difference at play, at least for
viral NP mRNA nuclear export. For this reason, A549 cells appear to be the
better cell model.

Future Directions

Future direction of this study should be to examine the role of other
nuclear export pathways in influenza A mRNA nuclear export. UAP56 is

known to be upstream of both NXF1 and Crm1, and siRNA data supports the
conclusion that Crm1 does not play a role in influenza mRNA nuclear export
(Figure15). However, Leptomyocin B treatment to block Crm1 export in both
A549 and 293T cells, would confirm this pathway is not used in A549 cells as
well as previous findings in 293T cells. The next step would be to determine
whether or not exportin-t or exportin-5 play roles in influenza A mRNA nuclear

export. This would involve co-immunopurification experiments for each, as
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well as pathway inhibition experiments. Beyond these experiments, if the

polymerase mRNAs are not dependent upon Nxfl, Crm1, exportin-t, or
exportin-5 mediated mRNA nuclear export, which protein is responsible for

their export? Is it host or viral? Regardless of its origin, if it is responsible for
the nuclear export of RdRP mRNAs, then it should be interacting with the

mRNA. The viral mRNAs can be used to biochemically or genetically screen

for interacting proteins. For example, a yeast three hybrid, or a biochemical
pull down of modified mRNAs. The answer to these questions could provide

very exciting revelations in our understanding of the human cell, or even

provide novel influenza antiviral targets. My thesis lays the groundwork for
future revelations.
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